Syneos Health

From WikiMD's WELLNESSPEDIA

File:Syneos Health logo.svg
Syneos Health logo

Syneos Health is a multinational contract research organization (CRO) that provides a range of clinical development and commercialization services to the biopharmaceutical industry. The company is known for its integrated approach to clinical trials and its ability to manage complex clinical studies across various therapeutic areas.

History[edit]

Syneos Health was formed through the merger of INC Research and inVentiv Health in 2017. This merger combined INC Research's expertise in clinical development with inVentiv Health's commercialization capabilities, creating a comprehensive service provider for the biopharmaceutical industry.

Services[edit]

Syneos Health offers a wide array of services that span the entire lifecycle of a drug, from early-phase clinical trials to post-market commercialization. These services include:

Global Presence[edit]

Syneos Health operates in more than 110 countries worldwide, providing its services to a diverse range of clients, including pharmaceutical companies, biotechnology firms, and medical device manufacturers. The company's global reach allows it to conduct clinical trials in various regions, ensuring diverse patient populations and compliance with local regulatory requirements.

Innovation and Technology[edit]

Syneos Health is committed to leveraging technology and innovation to enhance the efficiency and effectiveness of clinical trials. The company utilizes advanced data analytics, artificial intelligence, and digital health solutions to optimize study design, patient recruitment, and data collection.

Corporate Social Responsibility[edit]

Syneos Health is dedicated to corporate social responsibility (CSR) and sustainability. The company engages in various initiatives to promote ethical business practices, environmental sustainability, and community engagement.

Leadership[edit]

The leadership team at Syneos Health is composed of experienced professionals from the healthcare and pharmaceutical industries. They are responsible for guiding the company's strategic direction and ensuring the delivery of high-quality services to clients.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Syneos_Health&oldid=6296347"